Posted: May 27, 2019
Scott Antonia, MD, PhD, was appointed director of the newly formed DCI Center for Cancer Immunotherapy at Duke Cancer Institute. In addition to his leadership role, Dr. Antonia will also serve as professor of medical oncology.
In his previous roles at H. Lee Moffitt Cancer Center, he built an active lung cancer clinical research program and was recognized as Physician of the Year (2005), Mentor of the Year (2008), and Researcher of the Year (2018). Dr. Antonia was the global principal investigator for the practice-changing PACIFIC study. (For a post-PACIFIC perspective on barriers in patient care in Europe, read the article by Mirjana Rajer, MD) He was also the lead investigator of trials that established the clinical activity of immunotherapy for SCLC, which resulted in updated National Comprehensive Cancer Network guidelines.
